POM
PomDoctor Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · CN
$1.99
+10.56%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +17.7%
- EBITDA
- —
- EBIT
- —
- Net income
- -48.3%
- EPS
- +3.3%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026